Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Genetic hemochromatosis is mainly related to the homozygous p.Cys282Tyr (C282Y) mutation in the HFE gene, which causes hepcidin deficiency.
|
30244162 |
2019 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysregulation of hepcidin production contributes to the pathogenesis of many iron disorders: hepcidin deficiency causes iron overload in hereditary hemochromatosis and non-transfused β-thalassemia, whereas overproduction of hepcidin is associated with iron-restricted anemias seen in patients with chronic inflammatory diseases and inherited iron-refractory iron-deficiency anemia.
|
30798807 |
2019 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Deregulation of hepcidin expression is a common feature of genetic and acquired iron disorders: in Hereditary Hemochromatosis (HH) and iron-loading anemias low hepcidin causes iron overload, while in Iron Refractory Iron Deficiency Anemia (IRIDA) and anemia of inflammation (AI), high hepcidin levels induce iron-restricted erythropoiesis.
|
30798817 |
2019 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
A failure of iron to appropriately regulate liver hepcidin production is central to the pathogenesis of hereditary hemochromatosis.
|
31127639 |
2019 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The inability to appropriately regulate hepcidin production in response to these physiologic cues underlies genetic disorders of iron overload and deficiency, including hereditary hemochromatosis and iron-refractory iron deficiency anemia.
|
30401708 |
2019 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Severe types of HH are caused by either bi-allelic mutations of HFE2 that encodes hemojuvelin (type 2A) or HAMP that encodes hepcidin (type 2B).
|
29134618 |
2018 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
HJV and HAMP HH are phenotypically and clinically very similar and have the most severe presentation, with cardiomyopathy and hypogonadism being particularly prevalent findings.
|
29743178 |
2018 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Notably, adenine-rich diet significantly ameliorated iron overload accompanied by the enhanced hepcidin expression in both high iron-fed mice and in Hfe<sup>-/-</sup> mice, a murine model of hereditary hemochromatosis.
|
29600572 |
2018 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Iron-loading disorders, such as hereditary hemochromatosis, are associated with inappropriately low expression of the iron regulatory hormone, hepcidin.
|
29799786 |
2018 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Hereditary hemochromatosis (HH), a disease marked by chronic iron overload from insufficient expression of the hormone hepcidin, is one of the most common genetic diseases.
|
29388418 |
2018 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Small Molecule Inhibitors of NFkB Reverse Iron Overload and Hepcidin Deregulation in a Zebrafish Model for Hereditary Hemochromatosis Type 3.
|
29897731 |
2018 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hereditary Hemochromatosis (HH) is a genetically heterogeneous disorder caused by mutations in at least five different genes (HFE, HJV, TFR2, SLC40A1, HAMP) involved in the production or activity of the liver hormone hepcidin, a key regulator of systemic iron homeostasis.
|
28335084 |
2017 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Disturbances in the regulation of hepcidin contribute to the pathogenesis of many iron disorders: hepcidin deficiency causes iron overload in hereditary hemochromatosis and nontransfused β-thalassemia, whereas overproduction of hepcidin is associated with iron-restricted anemias seen in patients with chronic kidney disease, chronic inflammatory diseases, some cancers, and inherited iron-refractory iron deficiency anemia.
|
28096133 |
2017 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Juvenile hemochromatosis is a rare but the most severe form of hereditary hemochromatosis which develops due to mutations in the HJV or HAMP genes.
|
28363629 |
2017 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Patients with hereditary hemochromatosis, despite extreme iron storage, do not show increased manifestation of atherosclerosis probably due to the low expression of hepcidin in macrophages.
|
28379030 |
2017 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hemochromatosis (HH) is a group of inherited iron-overload disorders associated with pathogenic defects in the genes encoding hemochromatosis (HFE), hemojuvelin (HJV/HFE2), hepcidin (HAMP), transferrin receptor 2 (TfR2), and ferroportin (FPN1/SLC40A1) proteins, and the clinical features are well described.
|
27896572 |
2017 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The identification of hepcidin and its role will provide a better understanding for pathogenesis of HH.
|
27031690 |
2016 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
However, in certain geographical regions like the Mediterranean area, up to 30% of patients with a HH phenotype has a negative or non-diagnostic (i.e. simple heterozygosity) test, because of a known heterogeneity involving at least four other genes (HAMP, HJV, TFR2, and SLC40A1).
|
26799139 |
2016 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
However, whether HFE-HH and HJV-HH share a common pathway via hepcidin regulation is currently unclear.
|
25608116 |
2015 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Innately low hepcidin levels lead to iron overload in HFE-associated hereditary haemochromatosis.
|
25277871 |
2015 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The majority of the hereditary hemochromatosis (HH) patients are now shown to have mutations in the genes coding either upstream or downstream proteins of hepcidin, resulting in iron overload.
|
25737209 |
2015 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Diagnostic genetic testing for hereditary hemochromatosis is readily available for clinically relevant HFE variants (i.e., those that generate the C282Y, H63D and S65C HFE polymorphisms); however, genetic testing for other known causes of iron overload, including mutations affecting genes encoding hemojuvelin, transferrin receptor 2, HAMP, and ferroportin is not.
|
26142323 |
2015 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
|
25976471 |
2015 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
This study evaluated hepcidin secretion and iron burden after LT to elucidate HH pathophysiology.
|
23775519 |
2014 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in certain genes influencing signaling to hepcidin via the BMP/SMAD pathway are associated with human disorders of iron metabolism, such as hereditary hemochromatosis and iron-refractory iron-deficiency anemia.
|
24995692 |
2014 |